Piramal Pharma Financials
NSE: PPLPHARMA | BSE: 543635
₹214.22
₹-0.27
(-0.13%)
As on 04-Sep-2026 15:31IST
Market cap
₹28,351 Cr
Revenue (TTM)
₹9,205 Cr
P/E Ratio
--
P/B Ratio
3.5
Div. Yield
0 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
9,205.28
|
8,869.08
|
9,151.18
|
8,171.16
|
7,081.55
|
6,559.10
|
|
|
|
|
|
|
Total Income
|
9,449.59
|
9,111.51
|
9,312.95
|
8,372.30
|
7,306.66
|
6,834.90
|
|
|
|
|
|
|
Total Expenditure
|
8,195.15
|
7,976.59
|
7,733.31
|
7,000.65
|
6,453.31
|
5,609.44
|
|
|
|
|
|
|
EBITDA
|
1,010.13
|
892.49
|
1,417.87
|
1,170.51
|
628.24
|
949.66
|
|
|
|
|
|
|
Depreciation
|
857.51
|
831.24
|
816.34
|
740.57
|
676.69
|
586.18
|
|
|
|
|
|
|
EBIT
|
152.62
|
61.25
|
601.53
|
429.94
|
-48.45
|
363.48
|
|
|
|
|
|
|
Interest
|
342.73
|
340.80
|
421.59
|
448.49
|
344.18
|
198.25
|
|
|
|
|
|
|
Other Income
|
244.31
|
242.43
|
161.77
|
201.14
|
225.11
|
275.80
|
|
|
|
|
|
|
Exceptional Items
|
-216.88
|
-196.14
|
--
|
-62.79
|
-6.96
|
-15.08
|
|
|
|
|
|
|
Profit before Tax
|
-162.68
|
-176.06
|
414.64
|
179.29
|
-120.15
|
484.98
|
|
|
|
|
|
|
Provision for Tax
|
209.13
|
149.88
|
323.51
|
161.47
|
66.31
|
109.02
|
|
|
|
|
|
|
Profit after Tax
|
-371.81
|
-325.94
|
91.13
|
17.82
|
-186.46
|
375.96
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Share of Associate
|
58.19
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Consolidated Profit
|
-313.62
|
-325.94
|
91.13
|
17.82
|
-186.46
|
375.96
|
|
|
|
|
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
8,162.62
|
8,162.62
|
8,125.47
|
7,911.37
|
6,773.50
|
6,696.60
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Non-Current Liabilities
|
5,044.14
|
4,529.41
|
3,392.72
|
2,644.64
|
3,812.00
|
2,902.58
|
|
|
|
|
|
|
Current Liabilities
|
4,758.28
|
4,874.74
|
3,850.56
|
4,369.30
|
3,851.04
|
3,118.01
|
|
|
|
|
|
|
Total Liabilities
|
17,965.04
|
17,723.32
|
15,513.53
|
15,082.63
|
14,566.53
|
12,822.45
|
|
|
|
|
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
10,211.52
|
10,258.66
|
9,487.47
|
9,460.84
|
9,593.07
|
8,565.30
|
|
|
|
|
|
|
Current Assets
|
7,191.66
|
7,308.11
|
5,881.28
|
5,464.47
|
4,843.47
|
4,151.89
|
|
|
|
|
|
|
Total Assets
|
17,965.04
|
17,723.32
|
15,513.53
|
15,082.63
|
14,566.53
|
12,822.45
|
|
|
|
|
|
|
Total Debt*
|
--
|
5,495.48
|
4,720.27
|
4,558.86
|
5,504.77
|
4,023.28
|
|
|
|
|
|
|
Net Current Assets
|
2,433.38
|
2,433.37
|
2,030.72
|
1,095.17
|
992.43
|
1,033.88
|
|
|
|
|
|
|
Contingent Liabilities
|
--
|
95.72
|
99.76
|
61.43
|
57.32
|
44.94
|
|
|
|
|
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
1,652.60
|
892.30
|
1,004.54
|
483.89
|
766.42
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
-826.03
|
-477.46
|
-434.01
|
-1,338.78
|
-1,812.10
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
-38.98
|
-440.83
|
-422.36
|
817.79
|
794.19
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
787.59
|
-25.99
|
148.17
|
-37.10
|
-251.49
|
|
|
|
|
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
-2.35
|
-2.46
|
0.69
|
0.13
|
-1.53
|
3.10
|
|
|
|
|
|
|
Cash EPS (₹)
|
-2.36
|
3.81
|
6.85
|
5.73
|
4.01
|
7.92
|
|
|
|
|
|
|
Adjusted Book Value (₹)
|
60.13
|
60.96
|
60.89
|
59.59
|
55.44
|
55.15
|
|
|
|
|
|
|
Dividend per Share (₹)
|
--
|
--
|
0.14
|
0.11
|
--
|
--
|
|
|
|
|
|
|
Cash Flow per Share (₹)
|
--
|
12.45
|
6.74
|
7.59
|
4.06
|
6.46
|
|
|
|
|
|
|
Free Cash Flow per Share (₹)
|
--
|
1.07
|
-1.85
|
-1.42
|
-6.51
|
-1.85
|
|
|
|
|
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
1.24
|
6.61
|
5.07
|
1.95
|
7.10
|
|
|
|
|
|
|
ROE (%)
|
-3.85
|
-4.04
|
1.14
|
0.24
|
-2.77
|
6.11
|
|
|
|
|
|
|
ROA (%)
|
-2.21
|
-1.98
|
0.60
|
0.12
|
-1.37
|
3.20
|
|
|
|
|
|
|
EBIT Margin (%)
|
1.66
|
0.69
|
6.57
|
5.26
|
-0.68
|
5.54
|
|
|
|
|
|
|
Net Margin (%)
|
-3.93
|
-3.58
|
0.98
|
0.21
|
-2.55
|
5.50
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
--
|
4.80
|
8.54
|
8.05
|
6.05
|
13.17
|
|
|
|
|
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
0.78
|
-3.08
|
11.99
|
15.39
|
7.97
|
3.87
|
|
|
|
|
|
|
EBIT Growth (%)
|
-70.53
|
-89.82
|
39.91
|
987.39
|
-113.33
|
-58.83
|
|
|
|
|
|
|
Net Profit Growth (%)
|
-487.23
|
-457.66
|
411.39
|
109.56
|
-149.60
|
-54.98
|
|
|
|
|
|
|
EPS Growth (%)
|
-418.95
|
-456.91
|
410.84
|
108.83
|
-149.29
|
-62.24
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
0.33
|
2.28
|
16.39
|
1.15
|
19.48
|
|
|
|
|
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
-91.24
|
--
|
326.26
|
956.95
|
--
|
--
|
|
|
|
|
|
|
Price / Book Value
|
3.54
|
2.24
|
3.69
|
2.16
|
1.21
|
--
|
|
|
|
|
|
|
Dividend Yield (%)
|
--
|
--
|
0.06
|
0.09
|
--
|
--
|
|
|
|
|
|
|
EV/EBITDA
|
26.01
|
19.72
|
21.49
|
15.40
|
15.66
|
3.98
|
|
|
|
|
|
|
Close Price (₹)
|
168.09
|
136.54
|
224.75
|
128.90
|
66.85
|
--
|
|
|
|
|
|
|
High Price (₹)
|
220.90
|
241.00
|
307.90
|
149.00
|
197.08
|
--
|
|
|
|
|
|
|
Low Price (₹)
|
132.30
|
132.30
|
129.10
|
61.72
|
61.62
|
--
|
|
|
|
|
|
|
Market Cap (₹ Cr)
|
28,351.06
|
18,108.89
|
29,731.27
|
17,053.21
|
8,165.74
|
--
|
|
|
|
|
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.53
|
0.68
|
0.59
|
0.58
|
0.81
|
0.60
|
|
|
|
|
|
|
Short term debt to equity ratio
|
--
|
0.09
|
0.12
|
0.15
|
0.19
|
0.10
|
|
|
|
|
|
|
Current Ratio
|
1.51
|
1.50
|
1.53
|
1.25
|
1.26
|
1.33
|
|
|
|
|
|
|
Quick Ratio
|
0.87
|
0.87
|
0.93
|
0.75
|
0.82
|
0.89
|
|
|
|
|
|
|
Interest Coverage
|
0.53
|
0.48
|
1.98
|
1.40
|
0.65
|
3.45
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
23.44
|
24.33
|
25.67
|
26.12
|
25.41
|
27.22
|
|
|
|
|
|
|
Asset Turnover
|
0.55
|
0.64
|
0.70
|
0.64
|
0.60
|
0.62
|
|
|
|
|
|
|
Receivable days
|
--
|
78.20
|
77.05
|
76.20
|
80.70
|
83.94
|
|
|
|
|
|
|
Inventory Days
|
--
|
93.30
|
77.13
|
74.72
|
69.11
|
65.47
|
|
|
|
|
|
|
Payable days
|
--
|
226.14
|
173.49
|
168.73
|
149.81
|
144.76
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
-54.64
|
-19.30
|
-17.80
|
0.00
|
4.65
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
